AWS
RVLP

Atria Wealth Solutions’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Atria Wealth Solutions’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-23,000
Closed -$26.2K – 2013
2023
Q1 		$26.2K Hold
23,000
– – ﹤0.01% 1832
2022
Q4 		$25.8K Sell
23,000
-4,000
-15% -$6.38K ﹤0.01% 1774
2022
Q3 		$56.7K Hold
27,000
– – ﹤0.01% 1687
2022
Q2 		$37K Sell
27,000
-8,400
-24% -$12.2K ﹤0.01% 1593
2022
Q1 		$60K Buy
+35,400
New +$50.6K ﹤0.01% 1696

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Atria Wealth Solutions's RVLP Position: Q2 2023 in Review

Atria Wealth Solutions sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2023, closing a stake of 23,000 shares — an estimated $26.2K sold.

Atria Wealth Solutions first reported a position in RVLP in Q1 2022 and held it in 5 quarters. The position peaked at $60K in Q1 2022. 36 funds tracked by Wall St. Rank hold RVLP as of Q2 2023.

  • Atria Wealth Solutions reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Atria Wealth Solutions sold 23,000 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2023, an estimated $26.2K.
  • Atria Wealth Solutions first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2022 and held it in 5 quarters.
  • Atria Wealth Solutions's RVL Pharmaceuticals plc Ordinary Shares position peaked at $60K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2023.

Based on Atria Wealth Solutions's 13F filing for Q2 2023, filed 3 Aug 2023.